Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -0.25
- Piotroski Score 7.00
- Grade Buy
- Symbol (CCEL)
- Company Cryo-Cell International, Inc.
- Price $8.43
- Changes Percentage (7.12%)
- Change $0.56
- Day Low $7.92
- Day High $8.43
- Year High $9.50
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
- Last Earnings 10/30/2024
- Ex-Dividend for 5/16 Dividend 11/15/2024
- Dividend Payable 11/29/2024
- Today N/A
- Next Earnings (Estimated) 10/15/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.16
- Trailing P/E Ratio -7.95
- Forward P/E Ratio -7.95
- P/E Growth -7.95
- Net Income $-9,521,669
Income Statement
Quarterly
Annual
Latest News of CCEL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Microsoft Corp's (MSFT) Strategic Partnership: Accelerating Enterprise AI with C3.ai
Microsoft Corporation (NASDAQ:MSFT) is partnering with C3.ai to boost enterprise artificial intelligence on Microsoft Azure. The US and China are ramping up AI investments for economic growth. NVIDIA'...
By Yahoo! Finance | 1 day ago -
Advanced Micro Devices (AMD)'s AI Accelerator Breakthrough: TensorWave's Massive GPU Cluster Plans for 2025
A list of top AI investors was published, highlighting the competition between the US and China in AI development. AMD, NVIDIA, and hedge fund interest in AI stocks are discussed. AMD's collaboration ...
By Yahoo! Finance | 1 day ago -
Snowflake Inc. (SNOW) Enhances Cross-Cloud Collaboration to Accelerate AI App Development and Data Sharing
A list of 15 AI news highlights Snowflake Inc. among AI stocks making waves. Elon Musk's influence in Trump's administration may lead to stricter AI safety standards, according to scientist Max Tegmar...
By Yahoo! Finance | 2 days ago
